Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Influenza

Free Subscription Articles published in Antimicrob Agents Chemother Retrieve available abstracts of 29 articles: HTML format Text format

Single Articles

December 2011
1. PIZZORNO A , Abed Y, Bouhy X, Beaulieu E, et al
   Impact of mutations at residue I223 of the neuraminidase protein on the resistance profile, replication level and virulence of the 2009 pandemic influenza virus.
   Antimicrob Agents Chemother. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. BELSER JA , Sleeman K, Pearce MB, Katz JM, et al
   Oseltamivir inhibits H7 influenza virus replication in mice inoculated by the ocular route.
   Antimicrob Agents Chemother. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   November 2011
3. GILCA R , Fortin E, Frenette C, Longtin Y, et al
   Seasonal variations in Clostridium difficile infections are associated with influenza and respiratory syncytial virus activity independently of antibiotic prescriptions: a time-series analysis in Quebec, Canada.
   Antimicrob Agents Chemother. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   October 2011
4. SUGAYA N , Kohno S, Ishibashi T, Wajima T, et al
   Efficacy, Safety, and Pharmacokinetics of Intravenous Peramivir in Children with 2009 Pandemic A (H1N1) Influenza Virus Infection.
   Antimicrob Agents Chemother. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   September 2011
5. KUMAR N , Sharma NR, Ly H, Parslow TG, et al
   Receptor tyrosine kinase inhibitors that block replication of influenza A and other viruses.
   Antimicrob Agents Chemother. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. HSU JT , Yeh JY, Lin TJ, Li ML, et al
   Identification of BPR3P0128 as an Inhibitor of Cap-Snatching Activities of Influenza Virus.
   Antimicrob Agents Chemother. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   August 2011
7. KITANO M , Itoh Y, Kodama M, Ishigaki H, et al
   Efficacy of single intravenous injection of peramivir against influenza B virus infection in ferrets and cynomolgus macaques.
   Antimicrob Agents Chemother. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. KOHNO S , Yen MY, Cheong HJ, Hirotsu N, et al
   Comparison of single-dose intravenous peramivir with oral oseltamivir in patients with seasonal influenza virus infection: A phase III randomized, double-blind study.
   Antimicrob Agents Chemother. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   July 2011
9. DUAN S , Boltz DA, Li J, Oshansky CM, et al
   A novel genotyping and quantitative analysis of neuraminidase inhibitor-resistance associated mutations in influenza A viruses by single nucleotide polymorphism analysis.
   Antimicrob Agents Chemother. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   May 2011
10. NAUGHTIN M , Dyason JC, Mardy S, Sorn S, et al
    Neuraminidase inhibitor sensitivity and receptor-binding specificity of Cambodian clade 1 highly pathogenic H5N1 influenza virus.
    Antimicrob Agents Chemother. 2011;55:2004-10.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
11. KOHNO S , Kida H, Mizuguchi M, Hirotsu N, et al
    Intravenous peramivir for treatment of influenza A and B infection in high-risk patients.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
12. RICHARD M , Ferraris O, Erny A, Barthelemy M, et al
    Combinatorial effect of two E119V+I222L framework mutations in the neuraminidase active site of H3N2 influenza virus on resistance to oseltamivir.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. WEEKS JN , Boyd KL, Rajam G, Ades EW, et al
    Combined immunotherapy with intravenous immune globulin and P4 peptide rescues mice from post-influenza pneumococcal pneumonia.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
14. BROWN AN , McSharry JJ, Weng Q, Adams JR, et al
    Zanamivir, at 600 mg Twice Daily, Inhibits Oseltamivir-Resistant 2009 pandemic H1N1 Influenza Virus in an in vitro Hollow Fiber Infection Model System.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. BROWN AN , Bulitta JB, McSharry JJ, Weng Q, et al
    The Effect of Half-Life on the Pharmacodynamic Index of Zanamivir Against Influenza Virus as Delineated by a Mathematical Model.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. ZHENG Q , Xia L, Wu WL, Zheng Z, et al
    Properties and therapeutic efficacy of broadly reactive chimeric and humanized H5-specific monoclonal antibodies against H5N1 influenza viruses.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. JONES JC , Settles EW, Brandt CR, Schultz-Cherry S, et al
    IDENTIFICATION OF THE MINIMAL ACTIVE SEQUENCE OF AN ANTI-INFLUENZA PEPTIDE.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. GIRAUD C , Manceau S, Oualha M, Chappuy H, et al
    High levels and safety of oseltamivir carboxylate plasma concentrations after nasogastric administration in critically ill children in a pediatric intensive care unit.
    Antimicrob Agents Chemother. 2011;55:433-5.
    PubMed     Text format     Related articles   
    
    
    
    December 2010
19. WUNDERLICH K , Juozapaitis M, Ranadheera C, Kessler U, et al
    Identification of high-affinity PB1-derivedpeptides with enhanced affinity to the PA protein of the influenza A virus polymerase.
    Antimicrob Agents Chemother. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
20. ROUAN MC , Gevers T, Roymans D, de Zwart L, et al
    Pharmacokinetics-pharmacodynamics of a respiratory syncytial virus fusion inhibitor in the cotton rat model.
    Antimicrob Agents Chemother. 2010;54:4534-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2010
21. KOHNO S , Kida H, Mizuguchi M, Shimada J, et al
    Efficacy and safety of intravenous peramivir for the treatment of seasonal influenza.
    Antimicrob Agents Chemother. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2010
22. NGUYEN HT , Sheu TG, Mishin VP, Klimov AI, et al
    Assessment of pandemic and seasonal influenza A (H1N1) virus susceptibility to neuraminidase inhibitors in three enzyme activity inhibition assays.
    Antimicrob Agents Chemother. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2010
23. BROWN A , McSharry JJ, Weng Q, Driebe EM, et al
    An In Vitro System for Modeling Influenza A Virus Resistance under Drug Pressure.
    Antimicrob Agents Chemother. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2010
24. ABED Y , Simon P, Boivin G
    Prophylactic Activity of Intramuscular Peramivir in Mice Infected with a Recombinant Influenza A/WSN/33 (H1N1) Virus Containing the H274Y Neuraminidase Mutation.
    Antimicrob Agents Chemother. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. SUGAYA N , Ohashi Y
    Long-Acting Neuraminidase Inhibitor Laninamivir Octanoate (CS-8958) versus Oseltamivir as Treatment for Children with Influenza Virus Infection.
    Antimicrob Agents Chemother. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2010
26. SLEEMAN K , Mishin VP, Deyde VM, Furuta Y, et al
    In vitro antiviral activity of favipiravir (T-705) against drug-resistant influenza and 2009 A(H1N1) viruses.
    Antimicrob Agents Chemother. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. OKOMO-ADHIAMBO M , Demmler-Harrison GJ, Deyde VM, Sheu TG, et al
    Detection E119V and E119I Mutations in Influenza A (H3N2) Viruses Isolated from an Immunocompromised Patient: Challenges in Diagnosis of Oseltamivir-Resistance.
    Antimicrob Agents Chemother. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. KARPENKO I , Deev S, Kiselev O, Charushin V, et al
    A NOVEL AZOLO-1,2,4-TRIAZINE-DERIVED INHIBITOR OF INFLUENZA A AND B VIRUS REPLICATION: ANTIVIRAL PROPERTIES, METABOLISM, AND PHARMACOKINETICS.
    Antimicrob Agents Chemother. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. TURNER RB , Fuls JL, Rodgers ND
    Effectiveness of hand sanitizers with and without organic acids for removal of rhinovirus from hands.
    Antimicrob Agents Chemother. 2010;54:1363-4.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

This service is provided by AMEDEO through an unrestricted educational grant from www.InfluenzaWorld.com, a Roche service.

Amedeo is a Flying Publisher website.    Design: